When the hand of AI falls on medicine
On AI’s ability to design viruses, what happens when nature turns off genes, developments in cancer care, nutrition, and more
AI's presence in healthcare news dominated this past week, with researchers using the technology to design bacteriophages, or viruses that attack bacteria. Dr. Abdul Ghafur notes that while AI did not create a virus, it helped decide the genome of the designed bacteriophages. This marks a new stage in biology where AI enters the design phase.
In cardiac disease prediction, AI tools show promise but are not yet ready for clinical use. Meanwhile, genetics research reveals how nature switches off human genes, based on a study from Pakistan. D.P. Kasbekar discusses how a Hyderabad scientist discovered why a debilitating genetic disorder, FRDA, affects only Eurasians. In cancer news, the Supreme Court requests 19 states and union territories to declare cancer a 'notifiable disease' for early detection.
Three common medicines, hydrochlorothiazide, voriconazole, and tacrolimus, were also declared carcinogenic by the International Agency for Research on Cancer, which could impact patient treatment options.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- When the hand of AI falls on medicine thehindu.com
